Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests (“2.0”) under CE Mark for self-test and professional use October 12, 2022October 12, 2022 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: Roche obtains CE mark for the SARS-CoV-2 Antigen…Roche to launch SARS-CoV-2 & Flu A/B Rapid…Roche COVID-19 At-Home Test granted FDA Emergency…Roche COVID-19 At-Home Test granted FDA Emergency…PerkinElmer to Donate 1 Million Rapid COVID-19…Thermo Fisher Scientific Confirms Detection of…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
